DDR1 signaling is essential to sustain Stat5 function during lactogenesis

Journal of Cellular Biochemistry

Volumn 97, Issue 1, 2006, Pages 109-121

  Faraci Orf, Elena ^a   McFadden, Catherine ^a   Vogel, Wolfgang F ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b Medical Sciences Building ^*  (Canada)

Author keywords

Collagen; Lactation; Mammary gland; Prolactin; Tyrosine kinase

Indexed keywords

BETA CASEIN; COLLAGEN; COLLAGEN RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; PROTEIN DDR1; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BASEMENT MEMBRANE; BREAST DEVELOPMENT; BREAST DUCT; BREAST EPITHELIUM; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; MAMMARY GLAND; MAMMARY GLAND FUNCTION; MILK PRODUCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; TISSUE TRANSPLANTATION;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; IMMUNOPRECIPITATION; LACTATION; MAMMARY GLANDS, ANIMAL; MEMBRANE PROTEINS; MICE; RECEPTOR PROTEIN-TYROSINE KINASES; STAT5 TRANSCRIPTION FACTOR;

ANIMALIA;

EID: 30044438639     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20618     Document Type: Article

References (40)

1. Ali S, Ali S. 1998. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways. J Biol Chem 273:7709-7716.
2. Alves F, Vogel W, Mossie K, Millauer B, Hofler H, Ullrich A. 1995. Distinct structural characteristics of discoidin I subfamily receptor tyrosine kinases and complementary expression in human cancer. Oncogene 10:609-618.
3. Alves F, Saupe S, Ledwon M, Schaub F, Hiddemann W, Vogel WF. 2001. Identification of two novel, kinase-deficient variants of discoidin domain receptor 1: Differential expression in human colon cancer cell lines. FASEB J 15:1321-1323.
4. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, Kelly PA, Ormandy CJ. 1999. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 210:96-106.
5. Chammas R, Taverna D, Cella N, Santos C, Hynes NE. 1994. Laminin and tenascin assembly and expression regulate Hell mouse mammary cell-differentiation. J Cell Sci 107:1031-1040.
6. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM. 2002. The alpha(2) integrin subunit-deficient mouse: A multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 161:337-344.
7. Clevenger CV, Kline JB. 2001. Prolactin receptor signal transduction. Lupus 10:706-718.
8. Cui Y, Riedlinger G, Miyoshi K, Tang W, Li CL, Deng CX, Robinson GW, Hennighausen L. 2004. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 24:8037-8047.
9. DeOme KB, Faulkin LJ, Bern HA, Blair PB. 1959. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 19:515.
10. Emerman JT, Pitelka DR. 1977. Maintenance and induction of morphological-differentiation in dissociated mammary epithelium on floating collagen membranes. In Vitro 13:316-328.
11. Fata JE, Werb Z, Bissell MJ. 2003. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6:1-11.
12. Gardner H, Kreidberg J, Koteliansky V, Jaenisch R. 1996. Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev Biol 175:301-313.
13. Heinzelmann-Schwarz VA, Gardiner-Garden M, Henshall SM, Scurry J, Scolyer RA, Davies MJ, Heinzelmann M, Kalish LH, Bali A, Kench JG, Edwards LS, Vanden Bergh PM, Hacker NF, Sutherland RL, O'Brien PM. 2004. Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10: 4427-4436.
14. Hennighausen L, Robinson GW. 2001. Signaling pathways in mammary gland development. Dev Cell 1:467-475.
15. Imagawa W, Bandyopadhyay GK, Nandi S. 1995. Analysis of the proliferative response to lysophosphatidic acid in primary cultures of mammary epithelium-Differences between normal and tumor-cells. Exp Cell Res 216:178-186.
16. Jones FE, Welte T, Fu XY, Stern DF. 1999. ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J Cell Biol 147:77-87.
17. Kabotyanski EB, Rosen JM. 2003. Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b. J Biol Chem 278:17218-17227.
18. Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM. 1999. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A. J Biol Chem 274:22484-22492.
19. Klinowska TCM, Soriano JV, Edwards GM, Oliver JM, Valentijn AJ, Montesano R, Streuli CH. 1999. Laminin and beta 1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol 215:13-32.
20. Kloth MT, Laughlin KK, Biscardi JS, Boerner JL, Parsons SJ, Silva CM. 2003. STAT5b, a mediator of synergism between c-Src and the epidermal growth factor receptor. J Biol Chem 278:1671-1679.
21. Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ. 1987. Influence of a reconstituted basement-membrane and its components on casein gene-expression and secretion in mouse mammary epithelial-cells. Proc Nat Acad Sci USA 84:136-140.
22. Long WW, Wagner KU, Lloyd KCK, Binart N, Shillingford JM, Hennighausen L, Jones FE. 2003. Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development 130:5257-5268.
23. Martens N, Wery M, Wang P, Braet F, Gertler A, Hooghe R, Vandenhaute J, Hooghe-Peters EL. 2004. The suppressor of cytokine signaling (SOCS)-7 interacts with the actin cytoskeleton through vinexin. Exp Cell Res 298:239-248.
24. Miyoshi K, Shillingford JM, Smith GH, Grimm SL, Wagner KU, Oka T, Rosen JM, Robinson GW, Hennighausen L. 2001. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 155:531-542.
25. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE. 1999. ErbB receptor-induced activation of Stat transcription factors is mediated by Src tyrosine kinases. J Biol Chem 274:17209-17218.
26. Ormandy CJ, Camus A, Barra J, Damotte JD, Lucas B, Buteau H, Edery M, Brousse N, Babinet C, Binart N, Kelly PA. 1997. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse. Genes Devt 11:167-178.
27. Paukku K, Valgeirsdottir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O. 2000. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-Src, Fyn, Jak1 or Jak2 kinases. Biochem J 345:759-766.
28. Popovic Z, Templeton DM. 2004. Iron accumulation and iron-regulatory protein activity in human hepatoma (HepG2) cells. Mol Cell Biochem 265:37-45.
29. Shillingford JM, Miyoshi K, Robinson GW, Grimm SL, Rosen JM, Neubauer H, Pfeffer K, Hennighausen L. 2002. Jak2 is an essential tyrosine kinase involved in pregnancy-mediated development of mammary secretory epithelium. Mol Endocrinol 16:563-570.
30. Silberstein GB. 2001. Tumour-stromal interactions- Role of the stroma in mammary development. Breast Cancer Res 3:218-223.
31. Streuli CH, Edwards GM, Delcommenne M, Whitelaw CBA, Burdon TG, Schindler C, Watson CJ. 1995. Stat5 as a target for regulation by extracellular-matrix. J Biol Chem 270:21639-21644.
32. Teglund S, Mckay C, Schuetz E, van Deursen JM, Stravopodis D, Wang DM, Brown M, Bodner S, Grosveld G, Ihle JN. 1998. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell 93:841-850.
33. Udy GB, Towers RP, Snell RG, Wilkins RJ, Park SH, Ram PA, Waxman DJ, Davey HW. 1997. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression. Proc Nat Acad Sci USA 94:7239-7244.
34. Vogel WF. 2001. Collagen-receptor signaling in health and disease. Eur J Dermatol 11:506-514.
35. Vogel W, Gish GD, Alves F, Pawson T. 1997. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol Cell 1:13-23.
36. Vogel WF, Aszodi A, Alves F, Pawson T. 2001. Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 21:2906-2917.
37. Wagner KU, Krempler A, Triplett AA, Qi YY, George NM, Zhu JQ, Rui H. 2004. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Mol Cell Biol 24:5510-5520.
38. Wiseman BS, Sternlicht MD, Lund LR, Alexander CM, Mott J, Bissell MJ, Soloway P, Itohara S, Werb Z. 2003. Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162:1123-1133.
39. Xi SC, Zhang Q, Gooding WE, Smithgall TE, Grandis JR. 2003. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Can Res 63:6763-6771.
40. Zoubiane GS, Valentijn A, Lowe ET, Akhtar N, Bagley S, Gilmore AP, Streuli CH. 2004. A role for the cytoskeleton in prolactin-dependent mammary epithelial cell differentiation. J Cell Sci 117:271-280.